X

Vous n'êtes pas connecté

  - HEALTHPOLICY-WATCH.NEWS - A La Une - 08/07/2024 12:54

FDA Approves Eli Lilly’s Kisunla for Early-Stage Alzheimer’s Patients

Eli Lilly’s Alzheimer’s therapy, donanemab, has received FDA approval, offering new hope for patients with early symptomatic Alzheimer’s disease. The newly approved treatment, branded Kisunla, is set to challenge existing therapies from Eisai and Biogen.  Clinical trials have shown Kisunla to be effective for individuals in the mild cognitive impairment or mild dementia stages of […]

Articles similaires

Sorry! Image not available at this time

Triglyceride-Glucose Index May Predict Faster Cognitive Decline in Early Phases of Alzheimer Disease

drugs.com - 30/Jun 15:06

MONDAY, June 30, 2025 -- For patients with mild cognitive impairment (MCI) associated with Alzheimer disease (AD), those in the highest tertile of the...

Sorry! Image not available at this time

Gabapentin for Back Pain Linked to Increased Risk for Dementia, MCI

drugs.com - 11/Jul 15:07

FRIDAY, July 11, 2025 -- For adults with chronic low back pain, gabapentin prescription is associated with an increased risk for dementia and mild...

Frequent gabapentin use linked to higher dementia and cognitive impairment risk

news.medical.net - 11/Jul 03:47

Receiving six or more prescriptions of the drug gabapentin for low back pain is associated with significantly increased risks of developing dementia...

Sorry! Image not available at this time

Autism Spectrum Disorder Clinical Trials 2025: EMA, PDMA, FDA Approvals, Medication, Therapies, Treatment Market, Mechanism ...

wn.com - 07/Jul 11:40

"Autism Spectrum Disorder Clinical Trials" Autism spectrum disorder companies, such as Astrogen, MapLight Therapeutics, Axial Therapeutics, Aardvark...

Sorry! Image not available at this time

Autism Spectrum Disorder Clinical Trials 2025: EMA, PDMA, FDA Approvals, Medication, Therapies, Treatment Market, Mechanism ...

wn.com - 07/Jul 11:40

"Autism Spectrum Disorder Clinical Trials" Autism spectrum disorder companies, such as Astrogen, MapLight Therapeutics, Axial Therapeutics, Aardvark...

Sorry! Image not available at this time

Is it Alzheimer’s? Hopkins doctor compiles answers to many questions in book – WYPR

one2ninety.org - 02/Jul 15:45

Dr. Peter V. Rabins has been studying the brain, and dementia in particular, for a half century, since before most Americans had heard of Alzheimer...

Myeloma Warriors, Can Teclistamab Fight for You?

medindia.net - 11/Jul 14:20

Teclistamab shows promising results in high-risk multiple myeloma patients, including those ineligible for trials due to previous therapies.

Sorry! Image not available at this time

How Can Counselors Guide Families Through the Realities of Dementia and Alzheimer’s?

christianpublishinghouse.co - 04/Jul 18:00

The article explores how Christian counselors address the unique challenges of dementia and Alzheimer’s, integrating biblical truths with...

Learning Alzheimer’s risk doesn’t cause distress, study shows

knowridge.com - 09/Jul 00:23

A new study reveals that learning about one’s risk for Alzheimer’s disease doesn’t cause emotional harm—but even those at high risk often lose...

These evening foods and drinks could harm your brain health and increase Alzheimer's risk

times of india - 01/Jul 09:28

Evening habits influence brain health. Alzheimer's disease is a major concern. Avoid heavy meals before bed for better sleep. Sugary drinks increase...

Les derniers communiqués